Innovations in an Expanding Category

Hi, from Bookmarked 👋

Welcome to Bookmarked, an editorial forum for aspiring and young ophthalmologists. Formerly known as MillennialEYE, Bookmarked presents articles to read and reference, to save and share, and to educate and empower.

YMDC members receive full access to the Bookmarked library; non-members can read a maximum of 5 articles per month.

Start Reading X

5 articles remaining. To gain access to the full YMDC Bookmarked library, become a member today. »

This article originally appeared in the May/June 2022 issue of MillennialEYE.

Practice

May/June 2022

Innovations in an Expanding Category

Ralph Chu, MD; I. Paul Singh, MD

Y. Ralph Chu, MD, and I. Paul Singh, MD, discuss the expanding array of options for treating presbyopia. Dr. Chu offers practical advice for implementation, finding patients in the practice using a recently published presbyopia classification system by severity, and how to educate patients and set appropriate expectations.

Ralph Chu, MD

Founder and Chief Medical Officer, Chu Vision Institute, Bloomington, Minnesota
yrchu@chuvision.com
Financial disclosure: AbbVie/Allergan, Bausch + Lomb, Carl Zeiss Meditec

I. Paul Singh, MD

President, The Eye Centers of Racine & Kenosha, Racine & Kenosha, Wisconsin
ipsingh@amazingeye.com
Financial disclosures: AbbVie/Allergan, Bausch + Lomb, Carl Zeiss Meditec, Glaukos, Ivantis, New World Medical, Nova Eye Medical, Nicox, iStar Medical, Sight Sciences